PLoS Computational BiologySystems BiologyPeer-reviewed journal article
Multi-omics subtyping of hepatocellular carcinoma patients using a Bayesian network mixture model
Polina SuteriD, Eva DazertiD, Jack KuipersiD, Charlotte K.Y. NgiD, Tuyana BoldanovaiD, Michael N. HalliD, Markus Hermann HeimiD, Niko BeerenwinkeliD
Abstract
Comprehensive molecular characterization of cancer subtypes is essential for predicting clinical outcomes and searching for personalized treatments. We present bnClustOmics, a statistical model and computational tool for multi-omics unsupervised clustering, which serves a dual purpose: Clustering patient samples based on a Bayesian network mixture model and learning the networks of omics variables representing these clusters. The discovered networks encode interactions among all omics variables and provide a molecular characterization of each patient subgroup. We conducted simulation studies that demonstrated the advantages of our approach compared to other clustering methods in the case where the generative model is a mixture of Bayesian networks. We applied bnClustOmics to a hepatocellular carcinoma (HCC) dataset comprising genome (mutation and copy number), transcriptome, proteome, and phosphoproteome data. We identified three main HCC subtypes together with molecular characteristics, some of which are associated with survival even when adjusting for the clinical stage. Cluster-specific networks shed light on the links between genotypes and molecular phenotypes of samples within their respective clusters and suggest targets for personalized treatments. Author summaryMulti-omics approaches to cancer subtyping can provide more insights into molecular changes in tumors compared to single-omics approaches. However, most multi-omics clustering methods do not take into account that gene products interact, for example, as parts of protein complexes or signaling networks. Here we present bnClustOmics, a Bayesian network mixture model for unsupervised clustering of multi-omics data, which can represent dependencies among molecular changes of various omics types explicitly. Unlike other approaches that use data from public interaction databases as ground truth, bnClustOmics learns the dependencies between genes from the analyzed multi-omics dataset. At the same time, our approach can also account for prior knowledge from public interaction databases and use it to guide network learning without losing the ability to learn new dependencies. We applied bnClustOmics to a multi-omics HCC dataset and identified three subtypes similar to those identified in other HCC studies. The cluster-specific networks learned by bnClustOmics revealed additional insights into the molecular characterization of the discovered subgroups and highlighted the changes in signaling networks leading to distinct HCC phenotypes.
- organism: human
- assay: whole-genome sequencing
- assay: whole-exome sequencing
- assay: bulk RNA-seq
- assay: proteomics
- research focus: clustering
- research focus: gene regulatory network inference
- research focus: differential expression
- approach: Bayesian inference
- approach: statistical model
- Citations
- 15
- FWCI
- 0.90
- Field percentile
- top 30%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A hierarchical clustering and data fusion approach for disease subtype discovery
Bastian Pfeifer, Michael G. Schimek·Journal of Biomedical InformaticsPeer-reviewed·Nov 30, 2020
- Novel cancer subtyping method based on patient-specific gene regulatory network
Mai Adachi Nakazawa, Yoshinori Tamada, … Yasushi Okuno·Scientific ReportsPeer-reviewed·Dec 8, 2021
- Development of Machine Learning Model for Pan-cancer Subgroup Identification using Multi-omics Data
Seema Khadirnaikar, Sudhanshu Kumar Shukla, S. R. Mahadeva Prasanna·bioRxiv·Sep 15, 2022
- Decoding Liver Cancer Prognosis: From Multi-omics Subtypes, Prognostic Models to Single Cell Validation
Yanbin Wang, Yuqi Wu, … Yanmei Zou·bioRxiv·Nov 4, 2024
- NEMO: Cancer subtyping by integration of partial multi-omic data
Nimrod Rappoport, Ron Shamir A·BioinformaticsPeer-reviewed·Jan 25, 2019
- PAMOGK: A Pathway Graph Kernel based Multi-Omics Clustering Approach for Discovering Cancer Patient Subgroups
Yasin I. Tepeli, Ali Burak Ünal, … Öznur Taştan·bioRxiv·Jun 17, 2020